GRAIL Announces Significant Progress with Multi-Cancer Early Detection Test Including FDA Breakthrough Device Designation May 13, 2019
Bicycle Therapeutics Enters Neuroscience Arena through Collaboration with Dementia Discovery Fund May 7, 2019
Axial Therapeutics Releases New Preclinical Data from AB-2004 Program Demonstrating Reduction of Microbiome-Derived Metabolites in Mouse Models with Autism Spectrum Disorder May 2, 2019
